格隆汇4月28日丨国药控股(01099.HK)发布公告,由于达到独立非执行董事任职年限原因,陈方若于2025年4月25日向董事会提出辞任独立非执行董事、提名委员会委员及战略与投资委员会委员职务,自替任者于公司股东大会上获委任之日起生效。同日,董事会决议建议委任陈威如为独立非执行董事。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.